|Articles|August 1, 2002
Oncology NEWS International
- Oncology NEWS International Vol 11 No 8
- Volume 11
- Issue 8
FDA to Collect $1.2 Billion in User Fees
WASHINGTON-President Bush has signed legislation that reauthorizes the Prescription Drug User Fee Act (PDUFA), first enacted in 1992 to speed up the FDA’s processing of new drug applications. PDUFA III is the second 5-year
Advertisement
WASHINGTONPresident Bush has signed legislation that reauthorizes thePrescription Drug User Fee Act (PDUFA), first enacted in 1992 to speed up theFDA’s processing of new drug applications. PDUFA III is the second 5-yearextension. It authorizes collection of $1.2 billion in user fees in the next 5years from companies submitting NDAs.
Articles in this issue
about 24 years ago
Medicaid Gives New Protections to Beneficiaries in Managed Care Plansabout 24 years ago
Prostate Cancer Cell Line Vaccine Promising in Phase II Trialabout 24 years ago
MoAb Targeting Death Receptor in Breast Cancerabout 24 years ago
Hanford I-131 Releases Did Not Increase Thyroid Cancer Riskabout 24 years ago
Chemo/Rituximab Is Effective as First-Line CLL Therapyabout 24 years ago
Diagnostic Dilemmaabout 24 years ago
Viral Agent ONYX-015 Targets p53-Deficient Cancer Cellsabout 24 years ago
Program Educates Teens About Testicular Cancer Self-Examabout 24 years ago
Better Colon Cancer Imaging With PET/CT Than With PET Aloneabout 24 years ago
Delayed Lung Cancer Screening Trial to Begin Enrollment 50,000 SubjectsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Gastric Cancers
2
FDA Grants Priority Review to Dostarlimab in dMMR/MSI-H Rectal Cancer
3
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer
4
Teclistamab Combo Earns EU Approval in Relapsed/Refractory Multiple Myeloma
5